Intelence and Dyspnea - a phase IV clinical study of FDA data

Summary:

Dyspnea is reported as a side effect among people who take Intelence (etravirine), especially for people who are male, 40-49 old, have been taking the drug for 1 - 2 years also take Isentress, and have Osteoporosis.

The phase IV clinical study analyzes which people have Dyspnea when taking Intelence. It is created by eHealthMe based on reports of 3,739 people who have side effects when taking Intelence from the FDA, and is updated regularly.

What is Intelence?

Intelence has active ingredients of etravirine. It is often used in hiv infection. eHealthMe is studying from 3,797 Intelence users. Check the latest studies of Intelence.

What is Dyspnea?

Dyspnea (difficult or laboured breathing) is found to be associated with 3,719 drugs and 6,067 conditions by eHealthMe. Check the latest studies of Dyspnea.

On Jul, 11, 2026

3,739 people reported to have side effects when taking Intelence.
Among them, 60 people (1.6%) have Dyspnea.

Among these 60 people:

How long have people been on Intelence when they have Dyspnea? *

What is the gender of people who have Dyspnea when taking Intelence? *

female: 17.86 %
male: 82.14 %

What is the age of people who have Dyspnea when taking Intelence? *

What are other drugs people take besides Intelence? *

What are other side effects people have besides Dyspnea? *

Diarrhea: 10 people, 16.67%
Fatigue (feeling of tiredness): 10 people, 16.67%
Rashes (redness): 9 people, 15.00%
Pain: 8 people, 13.33%
Abdominal Pain Upper: 7 people, 11.67%
Oedema Peripheral (superficial swelling): 7 people, 11.67%
Chest Pain: 7 people, 11.67%
Spinal Compression Fracture (fracture due to spinal compression on bone): 6 people, 10.00%
Glaucoma (increased fluid pressure in the eye with vision loss): 6 people, 10.00%
Helicobacter Test Positive: 6 people, 10.00%

What are the existing conditions these people have? *

Interstitial Lung Disease: 6 people, 10.00%
Kaposi's Sarcoma (a tumour caused by human herpes virus): 6 people, 10.00%
Osteoporosis (bones weak and more likely to break): 6 people, 10.00%
Asthma: 4 people, 6.67%
High Blood Pressure: 3 people, 5.00%
Lipodystrophy Acquired (a regional loss of subcutaneous adipose tissue which usually starts in the face, extends downward acquired): 3 people, 5.00%
Rashes (redness): 3 people, 5.00%
Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 3 people, 5.00%
Epicondylitis (tennis elbow): 3 people, 5.00%
Hiv Test Positive: 2 people, 3.33%

* Approximation only. Some reports may have incomplete information.

Do you take Intelence and have Dyspnea?

- Check whether Dyspnea is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Intelence:

Intelence (3,797 reports)

Dyspnea treatments and more:

Dyspnea (661,578 reports)

Browse all side effects of Intelence:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Dyspnea:

Dyspnea (3,719 drugs)

Browse all the conditions that are associated with Dyspnea:

Dyspnea (6,067 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on etravirine (the active ingredients of Intelence) and Intelence (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.